ID   GM133
AC   CVCL_B4FS
DR   cancercelllines; CVCL_B4FS
DR   IARC_TP53; 20808
DR   Wikidata; Q110432814
RX   PubMed=14961077;
RX   PubMed=23541792;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=14961077).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
RX   PubMed=14961077; DOI=10.1038/sj.onc.1207244;
RA   Wang Y.-L., Zhu S.-J., Cloughesy T.F., Liau L.M., Mischel P.S.;
RT   "p53 disruption profoundly alters the response of human glioblastoma
RT   cells to DNA topoisomerase I inhibition.";
RL   Oncogene 23:1283-1290(2004).
//
RX   PubMed=23541792; DOI=10.1016/j.yexcr.2013.03.025; PMCID=PMC4052403;
RA   Eibinger G., Fauler G., Bernhart E., Frank S., Hammer A.,
RA   Wintersperger A., Eder H., Heinemann A., Mischel P.S., Malle E.,
RA   Sattler W.;
RT   "On the role of 25-hydroxycholesterol synthesis by glioblastoma cell
RT   lines. Implications for chemotactic monocyte recruitment.";
RL   Exp. Cell Res. 319:1828-1838(2013).
//